Skip to main content
. 2022 Oct 29;11(21):6419. doi: 10.3390/jcm11216419

Table 5.

Subgroup analysis stratified by the combination of RHF and TyG index.

Prevalence of
Albuminuria *,
n (%)
Model 1 Model 2 Model 3
Variable OR (95% CI) p OR (95% CI) p OR (95% CI) p
RHF + Tertile of TyG
No RHF + T1 (n = 1627) 43 (2.6) (Reference)
No RHF + T2 (n = 1625) 53 (3.3) 1.24 (0.83–1.87) 0.30 1.33 (0.88–2.01) 0.18 1.18 (0.78–1.80) 0.43
No RHF + T3 (n = 1625) 73 (4.5) 1.73 (1.18–2.54) 0.005 1.99 (1.32–2.99) 0.001 1.07 (0.68–1.68) 0.78
RHF + T1 (n = 181) 5 (2.8) 1.05 (0.41–2.68) 0.92 1.33 (0.51–3.45) 0.56 0.95 (0.35–2.60) 0.92
RHF + T2 (n = 180) 14 (7.8) 3.11 (1.67–5.80) <0.001 3.87 (2.03–7.40) <0.001 2.40 (1.15–5.00) <0.001
RHF + T3 (n = 182) 45 (24.7) 12.10 (7.69–19.03) <0.001 15.47 (9.36–25.58) <0.001 5.77 (3.04–10.95) <0.001

* p < 0.001, Model 1: Unadjusted model, Model 2: Adjusted for age and sex, Model 3: Adjusted for age; sex; smoking and alcohol status; education and income levels; BMI; SBP; hemoglobin; eGFR(CKD-EPI); and past history of HTN, DM, and dyslipidemia Abbreviations: RHF—renal hyperfiltration; TyG index—triglyceride-glucose index; OR—odds ratio; CI—confidence interval; BMI—body mass index; SBP—systolic blood pressure; eGFR—estimated glomerular filtration rate; CKD-EPI—CKD Epidemiology Collaboration; HTN—hypertension; DM—diabetes mellitus.